Zobrazeno 1 - 10
of 24
pro vyhledávání: '"N E, Levchenko"'
Autor:
E. V. Levchenko, F. V. Moiseenko, S. V. Orlov, E. N. Imyanitov, A. E. Mikhnin, M. L. Gelfond, E. N. Slugin, S. M. Ergnyan, N. E. Levchenko, A. S. Zhabina, A. M. Ulitin, O. Yu. Mamontov, O. O. Lopushanskaya, E. V. Artemeva, A. I. Murtazin, V. I. Shabinskaya
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 1, Pp 5-14 (2023)
Objective. To assess the overall and disease-free survival rates in patients with EGFR-mutated lung adenocarcinoma, who underwent surgery after achieving the objective response to tyrosine kinase inhibitor (TKI) therapy.Material and Methods. The over
Externí odkaz:
https://doaj.org/article/7336c9ed20724b46b7c9eb818dc1a744
Autor:
I. V. Kornienko, K. V. Stepanov, T. G. Faleeva, V. S. Rakuts, I. N. Ivanov, E. S. Mishin, N. V. Kononov, N. E. Levchenko, Y. S. Sidorenko
Publikováno v:
Теория и практика судебной экспертизы, Vol 14, Iss 2, Pp 107-114 (2019)
The question of whether it is appropriate to classify genetic examinations of kinship as a medical service is considered in the article. Establishment of identity of an unknown individual (alive or dead) with a specific person is a classic example of
Externí odkaz:
https://doaj.org/article/22c0e2d801994cce98e1a6281f4fc54c
Publikováno v:
Опухоли женской репродуктивной системы, Vol 14, Iss 2, Pp 82-89 (2018)
Despite the undeniable successes of modern medicine, the problems of oncology and, in particular, oncogynecology are still unresolved. Thus, a 5-year overall survival rate for stage I ovarian cancer is 89 %, for stage IV – 17 %. Given that complain
Externí odkaz:
https://doaj.org/article/c1f4a1cdfa7e4e638543a0cc2642e131
Autor:
R. I. Yurin, E. V. Levchenko, V. A. Gluscheko, A. E. Mikhnin, S. M. Ergnyan, L. V. Gorokhov, N. E. Levchenko, N. V. Khandogin
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 14, Iss 6, Pp 57-64 (2018)
The pain and pain syndrome remain to be serious problems of clinical medicine and surgery as one of its aspects. The positive correlation was found out between the type of surgery and post-operative pain in abdominal, thoracic and orthopedic surgerie
Externí odkaz:
https://doaj.org/article/af53c1e8a9b1435dbb0bb5677b854c7d
Publikováno v:
Опухоли женской репродуктивной системы, Vol 12, Iss 3, Pp 80-86 (2016)
The clinical case of seldom found pathology – primary cancer of the uterine tube including at the same time both epithelial and sarcomatous component of a tumor is described. Data on a cancer of a uterine tube which, being a rare tumor are submitte
Externí odkaz:
https://doaj.org/article/1e9e14c9322a4def9f0c999a1d7df335
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3-4, Pp 6-11 (2014)
In the cell there is a large class of regulatory molecules referred to as microRNA. Many investigators regard microRNA Mir and Mir-155 as new potential prognostic markers and targets for goal-oriented therapy for breast cancer (BC) these days. MiR-21
Externí odkaz:
https://doaj.org/article/510fa0c0f5eb4e5897cc8b70f7b2a3c4
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3-4, Pp 12-17 (2014)
Current therapeutic approaches based on a study of the genetic portrait of a tumor individualize treatment policy to a greater extent, which cre- ates real prospects for the increasing number of patients to recover. Experimental and clinical evidence
Externí odkaz:
https://doaj.org/article/c4e0f4edff8640d1b8f4db9a0f4f754a
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 3-4, Pp 86-89 (2014)
Currently, basic research in oncology focused on finding new potential markers of metastatic activity of tumor cells and rational approaches to cancer therapy. Constant search for biomarkers of endometrial cancer with high sensitivity and specificity
Externí odkaz:
https://doaj.org/article/eb0b168bbbd842dba3df523592d96201
Publikováno v:
Russian Journal of Oncology. 23:96-101
For many years ovarian cancer (OC) has remained the leading cause of mortality from gynecological cancer diseases. The problem of late diagnosis of ovarian cancer remains still unresolved in more than 70% of patients when the diagnosis is established
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8bb92669138126860666110d495dfe7
https://doi.org/10.18821/1028-9984-2018-23-2-96-101
https://doi.org/10.18821/1028-9984-2018-23-2-96-101
Autor:
Van Tin, E. D. Gumbatova, L. N. Shevkunov, O Yu Mamontov, Zhang Wen, K Yu Senchik, P S Kalinin, T. V. Dubinina, N E Levchenko, Evgeny Levchenko, Ya A. Ulianchenko, A. V. Mishchenko
Publikováno v:
Scopus-Elsevier
In order to create conditions for increasing the effectiveness of treatment of patients with metastatic lung disease a new method for calculating the dose of antitumor drug for performing isolated chemo-perfusion of the lung with metasta-sectomy taki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a548a88aca81e4cd3b1841c175f69633
https://doi.org/10.37469/0507-3758-2018-64-3-319-324
https://doi.org/10.37469/0507-3758-2018-64-3-319-324